Dr. Franz B. Humer is Venture Partner & Senior Advisor at Pappas Capital LLC, Chairman at Friends of Phelophepa Foundation, Chairman at Humer Foundation, Chairman at The International Centre for Missing & Exploited Children and a Member at European Round Table of Industrialists.
He is on the Board of Directors at Cydar Ltd., Arix Bioscience Plc, Kite Pharma, Inc., Wisekey USA, Inc., Citigroup, Inc., Chugai Pharmaceutical Co., Ltd., BIAL-Portela & Cia SA, Universität Salzburg, Walter Frey Holding AG and Emil Frey SA Genève.
Dr. Humer was previously employed as Vice Chairman by WISeKey International Holding Ltd., Chairman & Chief Executive Officer by Roche Holdings, Inc., Chairman by Diageo Plc, Chairman & Chief Executive Officer by Roche Group, Chief Operating Officer by F. Hoffmann-La Roche Ltd., Non-Executive Chairman by Roche Holding AG, General Manager by Schering-Plough Corp., General Manager by Kirby-Warrick Pharmaceuticals, Member-Supervisory Board by Allianz SE, Independent Non-Executive Director by Allianz Versicherungs-AG, a Principal by European Federation of Pharmaceutical Industries & Assns, a Managing Director by Glaxo Wellcome UK Ltd., and Chairman by INSEAD.
He also served on the board at Citibank NA, Glaxo Holdings Plc, Genentech, Inc., Jacobs Holding AG, Mondelez UK Holdings & Services Ltd. and WISeKey SA.
He received his MBA from INSEAD and a doctorate degree from the University of Innsbruck.